Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
More community healthcare needed in COVID-19 planning as chronic disease rates pressure hospitals
2021-10-13 05:00
Brii Bio Initiates Submission of Emergency Use Authorization Filing to U.S. FDA for BRII-196/BRII-198, its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients at High Risk of Clinical Progression to Severe Disease
2021-10-09 03:07
RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients
2021-10-04 21:24
Brii Bio Presents Positive Phase 3 Data on BRII-196/BRII-198, the Company's SARS-CoV-2 Monoclonal Neutralizing Antibody Combination Therapy, in an Oral Late-Breaker Presentation at IDWeek 2021
2021-10-04 08:00
Impact Credit Solutions and Bank Central Asia partner to offer financing to the Indonesian healthcare sector
2021-09-30 09:00
Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India
2021-09-28 14:57
Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy
2021-09-28 08:00
LEAD Horizon: How travelers in Austria gargle against the corona virus
2021-09-27 09:00
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
2021-09-24 08:47
/C O R R E C T I O N -- pHOXBIO/
2021-09-24 02:42
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine
2021-09-23 21:59
BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins
2021-09-23 15:00
INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico
2021-09-22 20:00
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug
2021-09-22 18:45
The International Standard Proposed by Experts from BMC Medical in Terms of High-flow Respiratory Therapy Equipment Officially Released
2021-09-22 15:00
FII Institute Launches Global Infectious Diseases Index
2021-09-21 23:19
Novavax to Participate in Fireside Chat at Devex @ UNGA 76
2021-09-21 04:46
P&G partners with Philippine Red Cross for COVID-19 Bakuna Buses in CALABARZON
2021-09-20 15:09
Experts Call on World Leaders to Commit to a Global Plan of Attack on COVID at Summit
2021-09-20 12:00
New Zealand's Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated
2021-09-20 06:00
1
19
20
21
22
23
71